Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis

Abstract

Angiotensin receptor blockers are associated with a significant reduction in the incidence and progression of Alzheimer's disease and dementia compared with angiotensin converting enzyme inhibitors or other cardiovascular drugs in a predominantly male population.